Gastric Adenocarcinoma — Trials

Gastric Adenocarcinoma — Trials · CancerIndex

Clinical trials

Registered studies

447 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 137
Recruiting: 69
Ph III recruiting: 12
Growth YoY: +31.3%
Industry share: 22%
Top sponsor: M.D. Anderson Cancer Center
Termination share: 31.2%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (52)

clinicaltrialsPublishedShowing 1–17 of 17 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT07529808	Phase 1/2 Study of BHB810 in Advanced Gastric and GEJ Adenocarcinoma	recruiting	Phase 1 / Phase 2	164	BigHat Biosciences, Inc.INDUSTRY	1	Sep 29, 2026	clinicaltrials
NCT07277413	A Study of IDE892 as Monotherapy and Combination in MTAP-deleted Advanced Solid Tumors	recruiting	Phase 1	260	IDEAYA BiosciencesINDUSTRY	1	Sep 28, 2026	clinicaltrials